Pilkington GJ - Search Results

1

The glial precursor proteoglycan, NG2, is expressed on tumour neovasculature by vascular pericytes in human malignant brain tumours.

Chekenya M, Enger PØ, Thorsen F, Tysnes BB, Al-Sarraj S, Read TA, Furmanek T, Mahesparan R, Levine JM, Butt AM, Pilkington GJ, Bjerkvig R. Chekenya M, et al. Among authors: pilkington gj. Neuropathol Appl Neurobiol. 2002 Oct;28(5):367-80. doi: 10.1046/j.1365-2990.2002.00412.x. Neuropathol Appl Neurobiol. 2002. PMID: 12366818

2

NG2 proteoglycan promotes angiogenesis-dependent tumor growth in CNS by sequestering angiostatin.

Chekenya M, Hjelstuen M, Enger PØ, Thorsen F, Jacob AL, Probst B, Haraldseth O, Pilkington G, Butt A, Levine JM, Bjerkvig R. Chekenya M, et al. FASEB J. 2002 Apr;16(6):586-8. doi: 10.1096/fj.01-0632fje. FASEB J. 2002. PMID: 11919162

3

NG2 precursor cells in neoplasia: functional, histogenesis and therapeutic implications for malignant brain tumours.

Chekenya M, Pilkington GJ. Chekenya M, et al. Among authors: pilkington gj. J Neurocytol. 2002 Jul-Aug;31(6-7):507-21. doi: 10.1023/a:1025795715377. J Neurocytol. 2002. PMID: 14501220 Review.

4

The NG2 chondroitin sulfate proteoglycan: role in malignant progression of human brain tumours.

Chekenya M, Rooprai HK, Davies D, Levine JM, Butt AM, Pilkington GJ. Chekenya M, et al. Among authors: pilkington gj. Int J Dev Neurosci. 1999 Aug-Oct;17(5-6):421-35. doi: 10.1016/s0736-5748(99)00019-2. Int J Dev Neurosci. 1999. PMID: 10571405

5

The role of growth factors in the malignant and invasive progression of intrinsic brain tumours.

Finn PE, Bjerkvig R, Pilkington GJ. Finn PE, et al. Among authors: pilkington gj. Anticancer Res. 1997 Nov-Dec;17(6B):4163-72. Anticancer Res. 1997. PMID: 9428350 Review.

6

Expression of the chondroitin sulphate proteoglycan, NG2, in paediatric brain tumors.

Higgins SC, Bolteus AJ, Donovan LK, Hasegawa H, Doey L, Al Sarraj S, King A, Ashkan K, Roncaroli F, Fillmore HL, Pilkington GJ. Higgins SC, et al. Among authors: pilkington gj. Anticancer Res. 2014 Dec;34(12):6919-24. Anticancer Res. 2014. PMID: 25503117

7

In vitro and in vivo models for the study of brain tumour invasion.

Pilkington GJ, Bjerkvig R, De Ridder L, Kaaijk P. Pilkington GJ, et al. Anticancer Res. 1997 Nov-Dec;17(6B):4107-9. Anticancer Res. 1997. PMID: 9428342 Review.

8

Dual targeting NG2 and GD3A using Mab-Zap immunotoxin results in reduced glioma cell viability in vitro.

Higgins SC, Fillmore HL, Ashkan K, Butt AM, Pilkington GJ. Higgins SC, et al. Among authors: pilkington gj. Anticancer Res. 2015 Jan;35(1):77-84. Anticancer Res. 2015. PMID: 25550537

9

Improved Drug Delivery to Brain Metastases by Peptide-Mediated Permeabilization of the Blood-Brain Barrier.

Aasen SN, Espedal H, Holte CF, Keunen O, Karlsen TV, Tenstad O, Maherally Z, Miletic H, Hoang T, Eikeland AV, Baghirov H, Olberg DE, Pilkington GJ, Sarkar G, Jenkins RB, Sundstrøm T, Bjerkvig R, Thorsen F. Aasen SN, et al. Among authors: pilkington gj. Mol Cancer Ther. 2019 Nov;18(11):2171-2181. doi: 10.1158/1535-7163.MCT-19-0160. Epub 2019 Aug 29. Mol Cancer Ther. 2019. PMID: 31467182

10

Glioma heterogeneity in vitro: the significance of growth factors and gangliosides.

Pilkington GJ. Pilkington GJ. Neuropathol Appl Neurobiol. 1992 Oct;18(5):434-42. doi: 10.1111/j.1365-2990.1992.tb00809.x. Neuropathol Appl Neurobiol. 1992. PMID: 1454133 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

137 results

Search Page